#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prodromal Alzheimer's disease Autoimmune haemolytic anaemia Congenital nephrogenic diabetes insipidus Pelizaeus-Merzbacher disease Albright's disease Epilepsy Chondrodystrophy Extranodal marginal zone B-cell lymphoma (MALT type) Canavan disease Neuroendocrine tumour of the lung Follicle centre lymphoma follicular grade I, II – III Endometrial cancer Factor VIII deficiency Myelofibrosis Metabolic disorder More trials…

    Learn about Rare Diseases

    Pleural mesothelioma malignant – Trials in Disease Haemophagocytic lymphohistiocytosis – Treatment Marginal zone lymphoma refractory – Treatment Alagille syndrome – Trials in Disease Uterine leiomyosarcoma – Treatment Osteosarcoma metastatic – Life with Disease Glycogen storage disease type V – Life with Disease Chordoma Prolymphocytic leukaemia – Diagnostics Basal cell naevus syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mirodenafil Dihydrochloride Potassium Protamine Sulfate Specific Nucleic Acid Sna-Xfsb Rp-1664 Sulfate PICLIDENOSON INF904 Metronidazole Dapansutrile ZILUCOPLAN Methylprednisolone Aceponate Ucart22 Asfotase Alfa Remdesivir STREPTOCOCCUS PYOGENES Celecoxib Olive Oil, Refined Trastuzumab Deruxtecan Idursulfase Interleukin-2 More therapies…

    Learn about Your Condition

    Acute myocardial infarction Alcoholic liver disease Guttate psoriasis Diabetic autonomic neuropathy Hypertriglyceridaemia Cardiac arrest Thyroidectomy Sjogren's syndrome Ligament operation Hepatic angiosarcoma Decreased appetite Amnestic disorder Metastases to liver Thrombectomy Rectal cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac failure chronic

  • Study on the Effects of Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) Using the CardioMEMS HF System

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Vericiguat
    • Placebo
    Denmark

  • Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Vericiguat
    Hungary Italy Poland Spain Sweden

  • Study on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure

    Not recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Azd5462
    Bulgaria Czechia Denmark Hungary The Netherlands Poland +1

  • Study on the Effects of Trimetazidine on Heart Failure with Preserved Ejection Fraction in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Trimetazidine Dihydrochloride
    Poland

  • Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Left ventricular failure
    • Cardiac failure acute
    • Cardiac failure chronic
    Investigated Drugs:
    • Cdr132L
    • Cdr132L Sodium
    Czechia Germany Greece Hungary The Netherlands Poland +1
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!